Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Klatskin Tumor × temoporfin × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1 Klatskin Tumor 1 Cholangiocarcinoma 1

Interventions

Capecitabine 6 Gemcitabine 5 Cisplatin 5 Liver Transplantation 4 Radiosurgery 3 Fluorouracil 3 toripalimab 2 Specimen Handling 2 Self Expandable Metallic Stents 2 Oxaliplatin 2 Magnetic Resonance Spectroscopy 2 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 2 trisacryl gelatin microspheres 1 tremelimumab 1 trametinib 1 tislelizumab 1 temoporfin 1 sacituzumab govitecan 1 pembrolizumab 1 lenvatinib 1 gemcitabine-oxaliplatin regimen 1 durvalumab 1 dehydroftorafur 1 Tegafur 1 Stents 1 Sorafenib 1 Saline Solution 1 S 1 (combination) 1 Radiofrequency Ablation 1 Platinum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03003065 2023-08-22

PDT

Chinese University of Hong Kong

Phase 2 Completed

Gastrointestinal

Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡